CIAM
KPRX icon

Caitong International Asset Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Caitong International Asset Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77K Buy
1,813
+1,807
+30,117% +$4.54K ﹤0.01% 1298
2026
Q1 		$12 Buy
+6
New +$13 ﹤0.01% 2123

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

Caitong International Asset Management's KPRX Position: Q2 2026 in Review

Caitong International Asset Management increased its Kiora Pharmaceuticals (KPRX) stake by 30,117% in Q2 2026, buying an estimated $4.54K and bringing the position to 1,813 shares worth $4.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

Caitong International Asset Management first reported a position in KPRX in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Caitong International Asset Management held 1,813 shares of Kiora Pharmaceuticals worth $4.77K as of Q2 2026.
  • Caitong International Asset Management bought 1,807 Kiora Pharmaceuticals shares in Q2 2026, an estimated $4.54K.
  • Kiora Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1298 holding.
  • Caitong International Asset Management first reported a position in Kiora Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.